428 related articles for article (PubMed ID: 18927958)
1. [Clinical use of botulinum toxin].
Jost WH
Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin. Development for therapeutic purposes].
Ceballos-Baumann A
Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxins for pain].
Soinila S; Haanpää M
Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
[TBL] [Abstract][Full Text] [Related]
4. Expanding use of botulinum toxin.
Bhidayasiri R; Truong DD
J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
[TBL] [Abstract][Full Text] [Related]
5. The effects of botulinum toxin in spasticity and headaches: a common key?
Sandrini G
Funct Neurol; 2008; 23(2):61. PubMed ID: 18671904
[No Abstract] [Full Text] [Related]
6. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
7. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
[No Abstract] [Full Text] [Related]
8. New therapeutic indications for botulinum toxins.
Cordivari C; Misra VP; Catania S; Lees AJ
Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
Panicker JN; Muthane UB
Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
[TBL] [Abstract][Full Text] [Related]
10. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
Calne S
Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
[TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin in tension-type headache].
Jost WH
Fortschr Neurol Psychiatr; 2003 Jun; 71(6):296-305. PubMed ID: 12796849
[TBL] [Abstract][Full Text] [Related]
12. The use of botulinum toxin in physical medicine and rehabilitation.
Cuevas-Trisán RL; Cruz-Jiménez M
Bol Asoc Med P R; 2006; 98(1):42-55. PubMed ID: 19610549
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic applications of botulinum toxin.
Thant ZS; Tan EK
Med Sci Monit; 2003 Feb; 9(2):RA40-8. PubMed ID: 12601305
[TBL] [Abstract][Full Text] [Related]
14. Dose standardization of botulinum toxin.
Van den Bergh PY; Lison DF
Adv Neurol; 1998; 78():231-5. PubMed ID: 9750920
[No Abstract] [Full Text] [Related]
15. Botulinum toxin in movement disorders.
Papapetropoulos S; Singer C
Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
[TBL] [Abstract][Full Text] [Related]
16. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
O'Brien CF
Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
[No Abstract] [Full Text] [Related]
17. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
[TBL] [Abstract][Full Text] [Related]
18. Application of botulinum toxin to clinical therapy: advances and cautions.
Levy NS; Lowenthal DT
Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
[TBL] [Abstract][Full Text] [Related]
19. [Indications and management of botulinum toxin].
Singer C
Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin-B and the management of hyperhidrosis.
Baumann LS; Halem ML
Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
